Fig. 3

Aspergillipeptide D affects HSV-1 late infection. a-bAspergillipeptide D reduces HSV-1 production and plaque size. The cells seeded in 24-well plates were treated with HSV-1 and Aspergillipeptide D for 2 h. The supernatant was then removed, and the cover fluid containing with Aspergillipeptide D was added. After 72 h, the cells were fixed, dyed, and the plaque inhibition rate was calculated. The size of plaque was measured and analyzed. Data are mean ± SD (n = 3), **p<0.01. c-eAspergillipeptide D has no significant effect on viral inactivation (c), penetration (d) and attachment (e), Data are mean ± SD (n = 3) [20]